Clinical Trials Identifier : NCT02234050Updated : 2017_02_06.
Descriptive Information :
Brief title :
Trabectedin for Recurrent Grade II/III Meningioma .
Official title :Trabectedin for Recurrent Grade II or III Meningioma: a Randomized Phase II Study of the EORTC Brain Tumor Group
Brief summary:
The aim of this study is to collect data on activity, toxicity and quality of life of Trabectedin therapy in patients with recurrent high-grade Meningioma.
Recruitment Information :
Status Recruiting :
Start date : 2015-07 .
Primary completion date 2017-07 (Anticipated) .
Administrative Data :
Organization Name : European Organisation for Research and Treatment of Cancer - EORTC .